Published in Can J Physiol Pharmacol on November 01, 1982
Myocardial reperfusion: a double-edged sword? J Clin Invest (1985) 4.12
Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J (1990) 2.04
Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med (2006) 1.97
Beta-adrenergic receptor signaling in the heart: role of CaMKII. J Mol Cell Cardiol (2009) 1.65
Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol (1996) 1.50
Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects. Heart Fail Rev (2007) 1.46
Oxidative Balance Score and Chronic Kidney Disease. Am J Nephrol (2015) 1.42
Review on in vivo and in vitro methods evaluation of antioxidant activity. Saudi Pharm J (2012) 1.37
Recombinant superoxide dismutase reduces oxygen free radical concentrations in reperfused myocardium. J Clin Invest (1987) 1.12
Long term effects of smoking on physical fitness and lung function: a longitudinal study of 1393 middle aged Norwegian men for seven years. BMJ (1995) 1.08
The antioxidant tempol attenuates pressure overload-induced cardiac hypertrophy and contractile dysfunction in mice fed a high-fructose diet. Am J Physiol Heart Circ Physiol (2008) 1.04
The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol (2002) 0.98
Stress cardiomyopathy mimicking acute coronary syndrome: case presentation and review of the literature. Clin Res Cardiol (2006) 0.95
Semiquinone anion radicals of catechol(amine)s, catechol estrogens, and their metal ion complexes. Environ Health Perspect (1985) 0.93
Myocardial diseases of animals. Am J Pathol (1986) 0.93
MiR-216a: a link between endothelial dysfunction and autophagy. Cell Death Dis (2014) 0.89
Stress cardiomyopathy: aetiology and management. Postgrad Med J (2007) 0.88
Rapid reversal of heart failure in a patient with phaeochromocytoma and catecholamine-induced cardiomyopathy who was treated with captopril. Br Heart J (1992) 0.88
Animal models of cardiac disease and stem cell therapy. Open Cardiovasc Med J (2010) 0.88
Tissue 65Zinc translocation in a rat model of chronic aldosteronism. J Cardiovasc Pharmacol (2008) 0.87
Reperfusion Injury: Basic Concepts and Protection Strategies. J Thromb Thrombolysis (1997) 0.84
Catecholamine cardiomyopathy: review and analysis of pathogenetic mechanisms. Yale J Biol Med (1991) 0.82
Dilated cardiomyopathy associated with chronic overuse of an adrenaline inhaler. Br Heart J (1992) 0.82
Mechanisms of alterations in cardiac membrane Ca2+ transport due to excess catecholamines. Cardiovasc Drugs Ther (1996) 0.82
Paeonol and danshensu combination attenuates apoptosis in myocardial infarcted rats by inhibiting oxidative stress: Roles of Nrf2/HO-1 and PI3K/Akt pathway. Sci Rep (2016) 0.81
Sundarban Honey Confers Protection against Isoproterenol-Induced Myocardial Infarction in Wistar Rats. Biomed Res Int (2016) 0.80
Ultrastructural alterations in the atrial myocardium of pigs with acute monensin toxicosis. Am J Pathol (1984) 0.79
Cardioprotective Effects of Essential Oil of Lavandula angustifolia on Isoproterenol-induced Acute Myocardial Infarction in Rat. Iran J Pharm Res (2015) 0.79
Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones. Prog Cardiovasc Dis (2012) 0.79
Amelioration of Isoproterenol-Induced Oxidative Damage in Rat Myocardium by Withania somnifera Leaf Extract. Biomed Res Int (2015) 0.79
Role of alpha 1-adrenoceptors in norepinephrine-induced cardiomyopathy. Am J Pathol (1985) 0.79
Tako-tsubo cardiomyopathy presenting with acute pulmonary edema. Congest Heart Fail (2009) 0.79
Anti-oxidized low-density lipoprotein antibodies in chronic heart failure. World J Cardiol (2012) 0.78
p38 MAP kinase inhibitor reverses stress-induced myocardial dysfunction in vivo. J Appl Physiol (1985) (2009) 0.78
The structural characteristics of the heart ventricle of the African lungfish Protopterus dolloi: freshwater and aestivation. J Anat (2008) 0.78
Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway. Exp Clin Cardiol (2011) 0.78
Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and Differences. Oxid Med Cell Longev (2016) 0.78
The cardioprotective effect of gamma-glutamylcysteine ethyl ester during coronary reperfusion in canine hearts. Br J Pharmacol (1991) 0.77
Citrus medica "Otroj": attenuates oxidative stress and cardiac dysrhythmia in isoproterenol-induced cardiomyopathy in rats. Nutrients (2013) 0.77
Mechanisms of cardioprotection resulting from Brown Norway chromosome 16 substitution in the salt-sensitive Dahl rat. Physiol Genomics (2012) 0.77
Cardioprotective response to chronic administration of vitamin E in isoproterenol induced myocardial necrosis: Hemodynamic, biochemical and ultrastructural studies. Indian J Clin Biochem (2007) 0.76
Aegle marmelos fruit extract attenuates isoproterenol-induced oxidative stress in rats. J Clin Biochem Nutr (2011) 0.76
Mineralocorticoid receptor antagonism confers cardioprotection in heart failure. Curr Heart Fail Rep (2013) 0.76
Standardized Chinese Formula Xin-Ke-Shu inhibits the myocardium Ca(2+) overloading and metabolic alternations in isoproterenol-induced myocardial infarction rats. Sci Rep (2016) 0.75
Butanolic fraction of Moringa oleifera Lam. (Moringaceae) attenuates isoprotrenol-induced cardiac necrosis and oxidative stress in rats: an EPR study. EXCLI J (2015) 0.75
Unusual case of left ventricular ballooning involving the inferior wall: a case report. Cases J (2009) 0.75
Catecholamine-induced transient myocardial dysfunction. BMJ Case Rep (2009) 0.75
Oral administration of quercetin is unable to protect against isoproterenol cardiotoxicity. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.75
Anthocyanin rich extract of Brassica oleracea L. alleviates experimentally induced myocardial infarction. PLoS One (2017) 0.75
Transient left ventricular apical ballooning following a prolonged ablation. J Interv Card Electrophysiol (2007) 0.75
Randomised controlled trial of brief psychological intervention after deliberate self poisoning. BMJ (2001) 3.46
Host resistance in sepsis and trauma. Ann Surg (1975) 2.56
Intimate partner violence and unwanted pregnancy, miscarriage, induced abortion, and stillbirth among a national sample of Bangladeshi women. BJOG (2007) 2.16
The role of oxidative stress in the genesis of heart disease. Cardiovasc Res (1998) 1.85
The neural systems sustaining face and proper-name processing. Brain (1998) 1.72
Shared characteristics of suicides and other unnatural deaths following non-fatal self-harm? A multicentre study of risk factors. Psychol Med (2011) 1.58
Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol (1996) 1.57
Activation of apoptotic processes during transition from hypertrophy to heart failure in guinea pigs. Am J Physiol Heart Circ Physiol (2007) 1.52
Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation (1997) 1.50
Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol (1996) 1.50
Bend propagation in the flagella of migrating human sperm, and its modulation by viscosity. Cell Motil Cytoskeleton (2009) 1.49
Item recognition is less impaired than recall and associative recognition in a patient with selective hippocampal damage. Hippocampus (2005) 1.45
Fatal Chromobacterium violaceum septicaemia. Singapore Med J (1993) 1.39
Tuberculosis in the Canadian Army 1939 to 1944. Can Med Assoc J (1945) 1.39
Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol (1983) 1.36
Differential cognitive effects of colloid cysts in the third ventricle that spare or compromise the fornix. Brain (2000) 1.28
A multicentre study of coproxamol poisoning suicides based on coroners' records in England. Br J Clin Pharmacol (2005) 1.28
Free radicals and the heart. J Pharmacol Toxicol Methods (1993) 1.27
Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol (1994) 1.26
Calcium movements in relation to heart function. Basic Res Cardiol (1982) 1.26
Confabulation and frontal lobe dysfunction. J Neurol Neurosurg Psychiatry (1980) 1.26
Structural and functional changes associated with failure and recovery of hearts after perfusion with Ca2+-free medium. J Mol Cell Cardiol (1975) 1.22
Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol (1978) 1.21
Neural activation during covert processing of positive emotional facial expressions. Neuroimage (1996) 1.20
Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. Antioxid Redox Signal (2001) 1.19
Suicide in recently discharged psychiatric patients: a case-control study. Psychol Med (2008) 1.17
Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation (1994) 1.16
Hospitalization for physical illness and risk of subsequent suicide: a population study. J Intern Med (2012) 1.15
Impact of the growing use of narrative verdicts by coroners on geographic variations in suicide: analysis of coroners' inquest data. J Public Health (Oxf) (2011) 1.15
Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol (1983) 1.15
Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med (1999) 1.14
Oxidative stress and heart failure. Mol Cell Biochem (1996) 1.12
Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis. Am J Pathol (1995) 1.11
Myocardial cation contents during induction of calcium paradox. Am J Physiol (1979) 1.11
Treatment of Essential Hypertension with Sodium Thiocyanate. Can Med Assoc J (1945) 1.10
Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol (2000) 1.09
Comparing two different methods of identifying alcohol related problems in the emergency department: a real chance to intervene? Emerg Med J (2001) 1.09
Time trends in coroners' use of different verdicts for possible suicides and their impact on officially reported incidence of suicide in England: 1990-2005. Psychol Med (2012) 1.08
Emergency department contact prior to suicide in mental health patients. Emerg Med J (2010) 1.07
Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation (1995) 1.07
Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am J Physiol (1991) 1.07
Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol (1999) 1.07
Development of cardiac sensitivity to oxygen deficiency: comparative and ontogenetic aspects. Physiol Rev (1999) 1.07
Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction. Mol Cell Biochem (2003) 1.06
Prostaglandins and heart disease. Can J Cardiol (1985) 1.05
Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes (2001) 1.04
Genetic analysis of temperature-sensitive lethal mutants of Salmonella typhimurium. Genetics (1989) 1.03
Correlation between antioxidant changes during hypoxia and recovery on reoxygenation. Am J Physiol (1991) 1.03
Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ Res (1986) 1.02
Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep (1998) 1.02
Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. Am J Physiol (1987) 1.02
Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. Circulation (2000) 1.02
Metallothioneins, oxidative stress and the cardiovascular system. Toxicology (2000) 1.01
Co-proxamol and suicide: preventing the continuing toll of overdose deaths. QJM (2005) 1.00
Depression of heart sarcolemmal Ca2+-pump activity by oxygen free radicals. Am J Physiol (1989) 0.99
Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol (2005) 0.99
Are hospital services for self-harm getting better? An observational study examining management, service provision and temporal trends in England. BMJ Open (2013) 0.99
Sarcoplasmic reticulum Ca(2+)/Calmodulin-dependent protein kinase is altered in heart failure. Circ Res (2000) 0.98
Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol (1985) 0.98
Alterations in Ca2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc Natl Acad Sci U S A (1983) 0.98
Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate. J Pharmacol Exp Ther (1999) 0.98
Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res Cardiol (1983) 0.98
The role of diencephalic pathology in human memory disorder. Evidence from a penetrating paranasal brain injury. Brain (1990) 0.97
Alterations in cardiac membrane Ca2+ transport during oxidative stress. Mol Cell Biochem (1990) 0.97
The neural basis of effective memory therapy in a patient with limbic encephalitis. J Neurol Neurosurg Psychiatry (2009) 0.97
Correlation between changes in the endogenous energy stores and myocardial function due to hypoxia in the isolated perfused rat heart. Can J Physiol Pharmacol (1972) 0.97
Sarpogrelate inhibits serotonin-induced proliferation of porcine coronary artery smooth muscle cells: implications for long-term graft patency. Ann Thorac Surg (2001) 0.96
Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure. Mol Cell Biochem (2000) 0.96
Lipid lowering: an important factor in preventing adriamycin-induced heart failure. Am J Pathol (1997) 0.95
Induction of necrosis and failure in the isolated perfused rat heart with oxidized isoproterenol. J Mol Cell Cardiol (1975) 0.95
Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J (1992) 0.94
Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. Am Heart J (1981) 0.94
Cardiac myofibrillar ATPase activity in diabetic rats. J Mol Cell Cardiol (1981) 0.94
Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy. Can J Cardiol (1985) 0.94
Excitation-contraction coupling in heart. 3. Evidence against the involvement of adenosine cyclic 3',5'-monophosphate in calcium transport by sarcotubular vesicles of canine myocardium. Mol Pharmacol (1970) 0.93
Sarcolemmal Na+-K+-ATPase activity in diabetic rat heart. Am J Physiol (1983) 0.93
Role of extracellular matrix proteins in heart function. Mol Cell Biochem (1993) 0.93
Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem (1997) 0.93
Sarcolemmal Ca2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats. Am J Physiol (1987) 0.93
Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. Am Heart J (2003) 0.92
Alterations in energy metabolism and ultrastructure upon reperfusion of the ischemic myocardium after coronary occlusion. Am J Cardiol (1975) 0.92
Increase in endogenous antioxidant enzymes protects hearts against reperfusion injury. Am J Physiol (1993) 0.92
Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes (1988) 0.92
Direct effects of adriamycin on the rat heart sarcolemma. Res Commun Chem Pathol Pharmacol (1984) 0.92
An ultrastructural study of the first cleavage of Xenopus embryos. J Ultrastruct Res (1974) 0.92
Subcutaneous panniculitis-like T-cell lymphoma in association with sarcoidosis. Clin Exp Dermatol (2011) 0.91